Interleukin-6-producing thymic squamous cell carcinoma associated with Castleman's disease and nephrotic syndrome

Internal Medicine

Volumn 41, Issue 10, 2002, Pages 871-874

  Matsumura, Norihiko ^a,b   Shiiki, Hideo ^a,b   Saito, Naotoshi ^a,b   Uramoto, Hiroki ^a,b   Hanatani, Masakazu ^a,b   Nonaka, Hideo ^a,b   Nakamura, Shinobu ^a,b  

^a Nara Prefectural Mimuro Hospital   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Mediastinal tumor

Indexed keywords

ACUTE PHASE PROTEIN; ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; INTERLEUKIN 6; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMORBIDITY; CORTICOSTEROID THERAPY; DRUG PULSE THERAPY; FEVER; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; MALE; MEDIASTINOSCOPY; MEDIASTINUM MASS; NEPHROTIC SYNDROME; PLASMA CELL; SQUAMOUS CELL CARCINOMA; THYMUS CANCER; TUMOR BIOPSY;

EID: 0036808728     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.871     Document Type: Article

References (22)

1. Kishimoto T. The biology of interleukin-6. Blood 74: 1-10, 1989.
2. Kirnbauer R, Kock A, Schwarz T, et al. IFN-β2, B cell differentiation factor 2 or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 142: 1922-1928, 1989.
3. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988.
4. Miki S, Iwano M, Miki Y, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607-610, 1989.
5. Matsuguchi T, Okamura S, Kawasaki C, et al. Constitutive production of granulocyte colony-stimulating factor and interleukin-6 by a human lung cancer cell line, KSNY: Gene amplification and increased mRNA stability. Eur J Haematol 47: 128-133, 1991.
6. Takano H, Harigaya K, Ishii G, et al. Interleukin-6 (IL-6) production in carcinoma of the cervix. Arch Gynecol Obstet 258: 25-33, 1996.
7. Oka M, Yamamoto K, Takahashi M, et al. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 56: 2776-2780, 1996.
8. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74: 1360-1367, 1989.
9. Chung DA. Thymic carcinoma-analysis of nineteen clinicopathological studies. Thorac Cardiov Surg 48: 114-119, 2000.
10. Morgenthaler TI, Brown LR, Colby TV, et al. Thymoma. Mayo Clin Proc 68: 1110-1123, 1993.
11. Ikeda T, Kawakami K, Fujita J, et al. Thymic carcinoma associated with a high serum level of interleukin 6 diagnosed through the evaluation for asymptomatic elevation of acute-phase reactants. Intern Med 37: 414-416, 1998.
12. Akimoto H, Shirai M, Usutani S, et al. Membranoproliferative glomerulonephritis-like lesion with fibrillary deposition associated with multi-centric Castleman's disease. Jpn J Nephrol 40: 301-308, 1998.
13. Keven K, Nergizoglu G, Ates K, et al. Remission of nephrotic syndrome after removal of localized Castleman's disease. Am J Kidney Dis 35: 1207-1211, 2000.
14. Kato Y, Kobayashi H, Mihara H, et al. Ticlopidine treatment in idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia accompanied by nephrotic syndrome. Intern Med 31: 504-507, 1992.
15. Horii Y, Muraguchi A, Iwano M, et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143: 3949-3955, 1989.
16. Horii Y, Iwano M, Hirata E, et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int Suppl 39: S71-75, 1993.
17. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29: 670-683, 1972.
18. McCarty MJ, Vukelja SJ, Banks PM, et al. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 21: 291-310, 1995.
19. Sato N, Asano S, Ueyama Y, et al. Granulocytosis and colony-stimulating activity (CSA) produced by a human squamous cell carcinoma. Cancer 43: 605-610, 1979.
20. Sato K, Mimura H, Han DC, et al. Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. J Clin Invest 78: 145-154, 1986.
21. Palestro G, Turrini F, Pagano M, et al. Castleman's disease. Adv Clin Path 3: 11-22, 1999.
22. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 5: 346-364, 1988.